Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The Global Health Investment Corporation (GHIC) is a nonprofit organization founded in 2012, with the mission of driving innovation in global public health. Established with support from the Bill & Melinda Gates Foundation and JP Morgan Chase, GHIC focuses on mobilizing private, public, and philanthropic capital to enhance the development and accessibility of health technologies. The organization specifically addresses urgent global health challenges, particularly those affecting low- and middle-income countries.
As of now, GHIC manages the Global Health Investment Fund (GHIF), a $108 million social impact fund that targets diseases disproportionately affecting low- and middle-income countries. The organization has successfully invested in 12 companies, demonstrating its commitment to improving global health outcomes. GHIC's strategic partnerships, including collaborations with BARDA and the German government, further enhance its capacity to respond to public health emergencies and support health innovations.
GHIC invests primarily in life sciences and healthcare technology companies that address pressing global health issues, including infectious diseases and maternal and child health. The organization’s main investment vehicle, the Global Health Investment Fund (GHIF), is a $108 million fund that targets diseases such as HIV/AIDS, malaria, tuberculosis, and cholera, which disproportionately affect low- and middle-income countries.
GHIC seeks to mobilize diverse capital sources to accelerate the development and access to products that improve global health. The organization looks for founders who demonstrate a strong commitment to addressing public health challenges and have innovative solutions that can scale effectively. GHIC also emphasizes partnerships with organizations like BARDA to enhance the capacity of its portfolio companies to respond to public health emergencies.
GHIC's portfolio consists of 12 companies that are focused on developing innovative solutions in diagnostics, vaccines, and therapeutics. Notable companies in the portfolio include:
These companies are instrumental in addressing global health challenges and have collectively reached over 500 million people with their products.
Labeeb M. Abboud: Chairman and CEO of GHIC, Abboud has extensive experience in public health and investment. He has led various initiatives aimed at improving global health outcomes.
Vidya Vasu-Devan: Chief Investment Officer and Senior Managing Director, Vasu-Devan has a strong background in healthcare investments and has been instrumental in shaping GHIC's investment strategy.
To pitch to GHIC, founders should use the contact form available on their website at ghicfunds.org/contact/. It is important to include a comprehensive overview of the startup, the problem it addresses, and the proposed solution. While specific response time expectations are not provided, founders should anticipate a thorough review process given GHIC's focus on impactful health solutions.
As of March 2026, GHIC has been actively mobilizing capital to support health technologies through its Global Health Investment Fund (GHIF), which is fully invested in 12 companies. The fund has reached over 500 million people globally with its portfolio products. GHIC has also established a 20-year partnership with the German government to accelerate public health technologies for low- and middle-income countries.
Additionally, GHIC has partnered with BARDA Ventures to co-invest in health security innovations aimed at enhancing responses to public health emergencies. This partnership reflects GHIC's commitment to addressing urgent global health challenges.
What are GHIC's investment criteria?
GHIC invests in life sciences and healthcare technology companies that address urgent global health challenges, particularly in low- and middle-income countries. The organization focuses on infectious diseases and maternal and child health.
How can startups apply or pitch to GHIC?
Startups can reach out through the contact form available on GHIC's website at ghicfunds.org/contact/. It is advisable to provide a detailed overview of the business model, the problem being addressed, and how the solution can scale.
What makes GHIC different from other investors?
GHIC is a nonprofit organization that mobilizes diverse capital sources to enhance global health technologies, focusing specifically on low- and middle-income countries. This unique approach allows GHIC to invest in areas that traditional venture capital firms may avoid due to lower immediate financial returns.
What is GHIC's geographic scope?
GHIC operates globally, with a specific focus on low- and middle-income countries that face significant public health challenges.
What kind of post-investment involvement does GHIC have?
GHIC provides strategic support to its portfolio companies, including partnerships with organizations like BARDA to enhance their capacity to respond to public health emergencies. This support often includes mobilizing additional funding and resources.
What is the size of GHIC's fund and check sizes?
The Global Health Investment Fund (GHIF) has a total size of $108 million, and while specific check sizes are not disclosed, the fund is fully invested in 12 companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.